首页> 外文期刊>Nature >CRISPR RNA maturation by trans- encoded small RNA and host factor RNase III
【24h】

CRISPR RNA maturation by trans- encoded small RNA and host factor RNase III

机译:CRISPR RNA通过转编码的小RNA和宿主因子RNase III成熟

获取原文
获取原文并翻译 | 示例
           

摘要

CRISPR/Cas systems constitute a widespread class of immunity systems that protect bacteria and archaea against phages and plasmids, and commonly use repeat/spacer-derived short crRNAs to silence foreign nucleic acids in a sequence-specific manner. Although the maturation of crRNAs represents a key event in CRISPR activation, the responsible endoribonucleases (CasE, Cas6, Csy4) are missing in many CRISPR/Cas subtypes. Here, differential RNA sequencing of the human pathogen Streptococcus pyogenes uncovered tracrRNA, a trans-encoded small RNA with 24-nucleotide complementarity to the repeat regions of crRNA precursor transcripts. We show that tracrRNA directs the maturation of crRNAs by the activities of the widely conserved endogenous RNase III and the CRISPR-associated Csnl protein; all these components are essential to protect S. pyogenes against prophage-derived DNA. Our study reveals a novel pathway of small guide RNA maturation and the first example of a host factor (RNase III) required for bacterial RNA-mediated immunity against invaders.
机译:CRISPR / Cas系统构成一类广泛的免疫系统,可以保护细菌和古细菌免受噬菌体和质粒的侵害,并且通常使用源自重复/间隔子的短crRNA来以序列特异性方式沉默外来核酸。尽管crRNA的成熟代表了CRISPR激活中的关键事件,但许多CRISPR / Cas亚型中缺少负责的核糖核酸内切酶(CasE,Cas6,Csy4)。在这里,人类病原体化脓性链球菌的差异RNA测序发现了tracrRNA,即与crRNA前体转录物的重复区域具有24个核苷酸互补性的反式编码小RNA。我们显示,tracrRNA通过广泛保守的内源性RNase III和CRISPR相关的Csnl蛋白的活性来指导crRNA的成熟;所有这些成分对于保护化脓性链球菌免受原噬菌体衍生的DNA至关重要。我们的研究揭示了小指导RNA成熟的新途径,以及细菌RNA介导的针对入侵者的免疫所必需的宿主因子(RNase III)的第一个实例。

著录项

  • 来源
    《Nature》 |2011年第7340期|p.602-607|共6页
  • 作者单位

    The Laboratory for Molecular Infection Medicine Sweden (MIMS), Umea Centre for Microbial Research (UCMR), Departmentof Molecular Biology, Umea University, S-90187 Umea, Sweden,Max F. Perutz Laboratories, Un iversity of Vienna, A-1030 Vienna, Austria;

    The Laboratory for Molecular Infection Medicine Sweden (MIMS), Umea Centre for Microbial Research (UCMR), Departmentof Molecular Biology, Umea University, S-90187 Umea, Sweden,Max F. Perutz Laboratories, Un iversity of Vienna, A-1030 Vienna, Austria;

    ZINF Research Center for Infectious Diseases, University of Wiirzburg, D-97080 Wuerzburg, Germany;

    Max F. Perutz Laboratories, Un iversity of Vienna, A-1030 Vienna, Austria;

    ZINF Research Center for Infectious Diseases, University of Wiirzburg, D-97080 Wuerzburg, Germany,RNA Biology Group, Institute for Molecular Infection Biology, University of Wuerzburg, D-97080 Wurzburg, Germany;

    Max F. Perutz Laboratories, Un iversity of Vienna, A-1030 Vienna, Austria;

    Max F. Perutz Laboratories, Un iversity of Vienna, A-1030 Vienna, Austria;

    ZINF Research Center for Infectious Diseases, University of Wiirzburg, D-97080 Wuerzburg, Germany,RNA Biology Group, Institute for Molecular Infection Biology, University of Wuerzburg, D-97080 Wurzburg, Germany;

    The Laboratory for Molecular Infection Medicine Sweden (MIMS), Umea Centre for Microbial Research (UCMR), Departmentof Molecular Biology, Umea University, S-90187 Umea, Sweden,Max F. Perutz Laboratories, Un iversity of Vienna, A-1030 Vienna, Austria;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号